D. C. Angus, C. A. Pereira, and E. Silva, Epidemiology of severe sepsis around the world, Endocr Metab Immune Disord Drug Targets, vol.6, pp.207-212, 2006.

D. Annane, E. Bellissant, and J. M. Cavaillon, Septic shock, Lancet, vol.365, pp.63-78, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01414960

M. W. Merx and C. Weber, Sepsis and the heart, Circulation, vol.116, pp.793-802, 2007.

S. D. Prabhu, Cytokine-induced modulation of cardiac function, Circ Res, vol.95, pp.1140-1153, 2004.

S. M. Hassoun, X. Marechal, D. Montaigne, Y. Bouazza, B. Decoster et al., Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction, Crit Care Med, vol.36, pp.2590-2596, 2008.

O. Joulin, S. Marechaux, S. Hassoun, D. Montaigne, S. Lancel et al., Cardiac force-frequency relationship and frequency-dependent acceleration of relaxation are impaired in LPS-treated rats, Crit Care, vol.13, p.14, 2009.

T. Ha, C. Lu, L. Liu, F. Hua, Y. Hu et al., TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism, Am J Physiol Heart Circ Physiol, vol.298, pp.984-991, 2010.

D. G. Harrison, J. Widder, I. Grumbach, W. Chen, M. Weber et al., Endothelial mechanotransduction, nitric oxide and vascular inflammation, J Intern Med, vol.259, pp.351-363, 2006.

T. Yamashita, S. Kawashima, Y. Ohashi, M. Ozaki, T. Ueyama et al., Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase, Circulation, vol.101, pp.931-937, 2000.

M. Vercauteren, R. E. Devaux, C. Dautreaux, B. Henry, J. P. Bauer et al., Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure, Circulation, vol.114, pp.2498-2507, 2006.

E. Gomez, M. Vercauteren, B. Kurtz, A. Ouvrard-pascaud, P. Mulder et al., Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B, J Mol Cell Cardiol, vol.52, pp.1257-1264, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00801304

M. I. Ali, P. Ketsawatsomkron, E. J. Belin-de-chantemele, J. D. Mintz, K. Muta et al., Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone, Circ Res, vol.105, pp.1013-1022, 2009.

J. M. Zabolotny, Y. B. Kim, L. A. Welsh, E. E. Kershaw, B. G. Neel et al., Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo, J Biol Chem, vol.283, pp.14230-14241, 2008.

E. J. Belin-de-chantemele, K. Muta, J. Mintz, M. L. Tremblay, M. B. Marrero et al., Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function, Circulation, vol.120, pp.753-763, 2009.

D. H. Maclennan and E. G. Kranias, Phospholamban: a crucial regulator of cardiac contractility, Nat Rev Mol Cell Biol, vol.4, pp.566-577, 2003.

E. G. Kranias and R. J. Hajjar, Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome, Circ Res, vol.110, pp.1646-1660, 2012.

C. W. Smith, M. L. Entman, C. L. Lane, A. L. Beaudet, T. I. Ty et al., Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1, J Clin Invest, vol.88, pp.1216-1223, 1991.

K. Höcherl, F. Dreher, A. Kurtz, and M. Bucher, Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure, Hypertension, vol.40, pp.947-953, 2002.

B. Levy, S. Collin, N. Sennoun, N. Ducrocq, A. Kimmoun et al., Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside, Intensive Care Med, vol.36, pp.2019-2029, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00666836

D. X. Zhang, F. X. Yi, A. P. Zou, and P. L. Li, Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries, Am J Physiol Heart Circ Physiol, vol.283, pp.1785-1794, 2002.

S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse et al., Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, vol.399, pp.601-605, 1999.

D. Fulton, J. P. Gratton, T. J. Mccabe, J. Fontana, Y. Fujio et al., Regulation of endothelium-derived nitric oxide production by the protein kinase Akt, Nature, vol.399, pp.597-601, 1999.

N. Matsuda, Y. Hayashi, Y. Takahashi, and Y. Hattori, Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy, J Pharmacol Exp Ther, vol.319, pp.1348-1354, 2006.

F. Tamion, F. Bauer, V. Richard, K. Laude, S. Renet et al., Myocardial dysfunction in early state of endotoxemia role of heme-oxygenase-1, J Surg Res, vol.158, pp.94-103, 2010.

N. Sennoun, F. Meziani, O. Dessebe, V. Cattan, C. S. Montemont et al., Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress, Crit Care Med, vol.37, pp.246-255, 2009.

A. Kumar, V. Thota, L. Dee, J. Olson, E. Uretz et al., Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum, J Exp Med, vol.183, pp.949-958, 1996.

C. D. Raeburn, C. M. Calkins, M. A. Zimmerman, Y. Song, L. Ao et al., ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation, Am J Physiol Regul Integr Comp Physiol, vol.283, pp.477-486, 2002.

S. Etienne-manneville, N. Chaverot, A. D. Strosberg, and P. O. Couraud, ICAM-1-coupled signaling pathways in astrocytes converge to cyclic AMP response element-binding protein phosphorylation and TNF-alpha secretion, J Immunol, vol.163, pp.668-674, 1999.

A. Clayton, R. A. Evans, E. Pettit, M. Hallett, J. D. Williams et al., Cellular activation through the ligation of intercellular adhesion molecule-1, J Cell Sci, vol.111, pp.443-453, 1998.

S. Berdnikovs, H. Abdala-valencia, and J. M. Cook-mills, Endothelial cell PTP1B regulates leukocyte recruitment during allergic inflammation, Am J Physiol Lung Cell Mol Physiol, vol.304, pp.240-249, 2013.

T. Zhang, X. Lu, P. Arnold, Y. Liu, R. Baliga et al., Mitogen-activated protein kinase phosphatase-1 inhibits myocardial TNF-? expression and improves cardiac function during endotoxemia, Cardiovasc Res, vol.93, pp.471-479, 2012.

T. Peng, T. Zhang, X. Lu, and Q. Feng, JNK1/c-fos inhibits cardiomyocyte TNF-alpha expression via a negative crosstalk with ERK and p38 MAPK in endotoxaemia, Cardiovasc Res, vol.81, pp.733-741, 2009.

T. Peng, X. Lu, M. Lei, G. W. Moe, and Q. Feng, Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia, Cardiovasc Res, vol.59, pp.893-900, 2003.

D. J. Duncan, Z. Yang, P. M. Hopkins, D. S. Steele, and S. M. Harrison, TNF-alpha and IL-1beta increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes, Cell Calcium, vol.47, pp.378-386, 2010.

R. Neviere, S. M. Hassoun, B. Decoster, Y. Bouazza, D. Montaigne et al., Caspase-dependent protein phosphatase 2A activation contributes to endotoxin-induced cardiomyocyte contractile dysfunction, Crit Care Med, vol.38, pp.2031-2036, 2010.

S. Lancel, S. M. Hassoun, R. Favory, B. Decoster, R. Motterlini et al., Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis, J Pharmacol Exp Ther, vol.329, pp.641-648, 2009.

K. L. Grinnell, H. Chichger, J. Braza, H. Duong, and E. O. Harrington, Protection against LPS-induced pulmonary edema through the attenuation of protein tyrosine phosphatase-1B oxidation, Am J Respir Cell Mol Biol, vol.46, pp.623-632, 2012.